Literature DB >> 17242135

Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement.

Tilmann Kallinich1, Dieter Haffner, Tim Niehues, Kristina Huss, Elke Lainka, Ulrich Neudorf, Christof Schaefer, Silvia Stojanov, Christian Timmann, Rolf Keitzer, Huri Ozdogan, Seza Ozen.   

Abstract

The daily application of colchicine is the standard therapy for prophylaxis of attacks and amyloid deposition in familial Mediterranean fever. However, because of many issues (eg, dosage, time of introduction, etc), no standardized treatment recommendations have been established. In this work we review the available literature on colchicine use with respect to its indication, efficacy, mode of application, and safety in children and adolescents with familial Mediterranean fever. On the basis of this analysis, a consensus statement on the application of colchicine in children and adolescents with familial Mediterranean fever was developed by caregivers from Germany, Austria, and Turkey.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17242135     DOI: 10.1542/peds.2006-1434

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  53 in total

1.  Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.

Authors:  Daria B Crittenden; R Aaron Lehmann; Laura Schneck; Robert T Keenan; Binita Shah; Jeffrey D Greenberg; Bruce N Cronstein; Steven P Sedlis; Michael H Pillinger
Journal:  J Rheumatol       Date:  2012-06-01       Impact factor: 4.666

Review 2.  Autoinflammatory Diseases with Periodic Fevers.

Authors:  Erdal Sag; Yelda Bilginer; Seza Ozen
Journal:  Curr Rheumatol Rep       Date:  2017-07       Impact factor: 4.592

Review 3.  [Drug therapy during pregnancy and breast feeding. Updated summary].

Authors:  K Krüger; E Gromnica-Ihle
Journal:  Z Rheumatol       Date:  2009-03       Impact factor: 1.372

4.  Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.

Authors:  Fehime Kara Eroglu; Nesrin Beşbaş; Rezan Topaloglu; Seza Ozen
Journal:  Rheumatol Int       Date:  2015-05-23       Impact factor: 2.631

Review 5.  The emerging role of interleukin-1β in autoinflammatory diseases.

Authors:  Thirusha Lane; Helen J Lachmann
Journal:  Curr Allergy Asthma Rep       Date:  2011-10       Impact factor: 4.806

Review 6.  Update on colchicine, 2017.

Authors:  Anastasia Slobodnick; Binita Shah; Svetlana Krasnokutsky; Michael H Pillinger
Journal:  Rheumatology (Oxford)       Date:  2018-01-01       Impact factor: 7.580

7.  Association of clinical and genetical features in FMF with focus on MEFV strip assay sensitivity in 452 children from western Anatolia, Turkey.

Authors:  Can Ozturk; Oya Halicioglu; Işil Coker; Nesrin Gulez; Sumer Sutçuoglu; Neslihan Karaca; Guzide Aksu; Necil Kutukculer
Journal:  Clin Rheumatol       Date:  2011-11-05       Impact factor: 2.980

8.  Familial Mediterranean fever in childhood: a single-center experience.

Authors:  Kenan Barut; Sezgin Sahin; Amra Adrovic; Ada Bulut Sinoplu; Gozde Yucel; Gizem Pamuk; Aslı Kirectepe Aydın; Selcuk Dasdemir; Eda Tahir Turanlı; Nur Buyru; Ozgur Kasapcopur
Journal:  Rheumatol Int       Date:  2017-08-21       Impact factor: 2.631

Review 9.  Familial Mediterranean fever: An updated review.

Authors:  İsmail Sarı; Merih Birlik; Timuçin Kasifoğlu
Journal:  Eur J Rheumatol       Date:  2014-03-01

Review 10.  Colchicine--Update on mechanisms of action and therapeutic uses.

Authors:  Ying Ying Leung; Laura Li Yao Hui; Virginia B Kraus
Journal:  Semin Arthritis Rheum       Date:  2015-06-26       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.